PrintThe Burrill Report
The Burrill Report (September 20, 2010): Crafting an Innovation Agenda (.MP3,11.11 Mb)
A group of venture investors and life sciences entrepreneurs have launched a new policy group they say will be focused on advancing medical innovation in the United States. The group, the Medical Innovation and Competitiveness Coalition, is meant to address an agenda that sometimes is neglected or ignored by the large life sciences trade groups. We spoke to Kelly Slone, a member of the steering committee of the coalition about the new group, policy areas of concern, and why they think it is needed today.
September 16, 2010
http://www.burrillreport.com/article-crafting_an_innovation_agenda.html
INNOVATION
Crafting an Innovation Agenda
Podcast: September 20, 2010[Please login to post comments]
- Deep Recession Fuels Rise in Uninsured
The number of people without health insurance in the United States rose to nearly 51 million. Read More - Liquid Fuel Directly from Sunlight
Joule awarded patent on renewable diesel production from sunlight and CO2. Read More - FDA Panel Rejects Obesity Drug
Arena’s shares plunge as panel says risks outweigh the benefits. Read More - Ramius Gets Hostile
Hedge fund manager takes its case directly to Cypress shareholders. Read More - Genmab Recalibrates
Strategic partnerships, cost-cutting key to strategy. Read More - Johnson & Johnson to Buy Dutch Vaccine Maker Crucell for $2.3 Billion
Deal will expand biopharma’s position in growing vaccine market. Read More - Forest Settles Criminal Investigation over Illegal Drug Marketing
The weekly round-up of failed trials, missed targets and other business mishaps. Read More - Investors Discount Arena’s Obesity Drug on FDA Briefing
Lorcaserin stumbles near finish line in race to bring new weight loss drug to market. Read More - Genzyme sells lab test unit to LabCorp
Troubled biotech looks to lighten its load. Read More - Roche Bets $635 Million on Parkinson's, Alzheimer's Programs
New partnership with Belgium's reMynd targets toxicity. Read More
.gif)
.gif)
- FDA staff question Arena diet drug, shares plunge
Reuters - Top Genentech research exec departing for academia
Reuters - Health Plan Won’t Fuel Big Spending, Report Says
The New York Times - Lilly Invests $150 Million With Venture Firms Seeking New Drug Candidates
Bloomberg - Genzyme Investors Push for Sanofi Bid of $75 a Share
Bloomberg - Sanofi's CEO Viehbacher Pitches Genzyme Investors in New York on Takeover
Bloomberg - Valeant, Biovail to cut 25 pct jobs of combined co
Reuters - Elan gets injunction vs directors, slams investor
Reuters - Sanofi Chief Extends Hand to Bypass Genzyme `Brick Wall'
Bloomberg - U.S. Court Rules Against Obama’s Stem Cell Policy
The New York Times